Therapy Areas: Inflammatory Diseases
Microbiome Insights Receives Funding from the government of Canada to Develop New Microbiome Testing Platform for Managing Chronic Disease
12 September 2018 - - Canada-based Microbiome Insights, Inc. will receive a contribution of up to USD190,249 from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to help support the development of a new personal health platform of microbiome testing, the company said.

Co-founded by Drs. Brett Finlay and Bill Mohn at University of British Columbia in 2015, Microbiome Insights is in microbiome testing and bioinformatic analysis.

The advisory services and financial assistance from the government of Canada, through NRC IRAP, will help the company expand in a new direction, continuing to develop tools for use in clinical settings as new data emerge on the gut microbiome and health.

The primary aim of the company's personal health platform is to help address the challenges both healthcare practitioners and individuals face in the management of chronic disease.

Microbiome monitoring in those with chronic disease may provide a tool for assessing response to therapies or to various lifestyle changes (including diet), particularly when integrated with robust research findings and ongoing data collection.

Microbiome Insights's new testing platform will be aimed at health practitioners helping individuals who live with inflammatory bowel disease.

The efforts are led by Nataša Jovic, MBA, who brings to the company twenty years of experience in therapeutic and diagnostic commercialisation.

Microbiome Insights is currently exploring opportunities to commercialize its platform of microbiome tests for healthcare practitioners through research collaborations and distribution or joint commercialisation efforts.
Login
Username:

Password: